Galectin Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.71 0.38 Jun/2026
Bristol-Myers Squibb 4.36 0.23 Jun/2026
Galectin Therapeutics 0 0 Mar/2025
Gilead Sciences 2.55 0.26 Jun/2026
Merck 2.62 0.14 Jun/2026